Last 12 months
Inside the activity.
0 purchase rows · 17 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 4 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 09, 2021 Filed Jun 12, 2021 00:33 UTC |
HASTINGS PAUL JDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,626 | $0.00 Strike: $60.96 | $0.00 |
DisclosureSEC source: 0001209191-21-040084 · doc4.xml · derivative · entry 2 HASTINGS PAUL J · CIK 0001309702 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,626 Underlying: Common Stock · 7,626 shares Expires 2031-06-09 Read SEC document |
| June 09, 2021 Filed Jun 12, 2021 00:33 UTC |
HASTINGS PAUL JDirector
|
GrantCommon Stock | 1,066 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-040084 · doc4.xml · nonDerivative · entry 1 HASTINGS PAUL J · CIK 0001309702 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,552 F1 · shares: Represents restricted stock units that vest on June 3, 2022, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 09, 2021 Filed Jun 12, 2021 00:30 UTC |
Brege LauraDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,626 | $0.00 Strike: $60.96 | $0.00 |
DisclosureSEC source: 0001209191-21-040079 · doc4.xml · derivative · entry 2 Brege Laura · CIK 0001365619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,626 Underlying: Common Stock · 7,626 shares Expires 2031-06-09 Read SEC document |
| June 09, 2021 Filed Jun 12, 2021 00:30 UTC |
Brege LauraDirector
|
GrantCommon Stock | 1,066 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-040079 · doc4.xml · nonDerivative · entry 1 Brege Laura · CIK 0001365619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,987 F1 · shares: Represents restricted stock units that vest on June 3, 2022, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 09, 2021 Filed Jun 12, 2021 00:48 UTC |
McLoughlin DennisChief Customer Officer
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $60.96 | $0.00 |
DisclosureSEC source: 0001209191-21-040098 · doc4.xml · derivative · entry 2 McLoughlin Dennis · CIK 0001752004 · Chief Customer Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2031-06-09 F2 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| June 09, 2021 Filed Jun 12, 2021 00:48 UTC |
McLoughlin DennisChief Customer Officer
|
GrantCommon Stock | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-040098 · doc4.xml · nonDerivative · entry 1 McLoughlin Dennis · CIK 0001752004 · Chief Customer Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,541 F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2022, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 09, 2021 Filed Jun 12, 2021 00:40 UTC |
REINHARDT MAXPresident, Rest of World
|
GrantStock Option (Right to Buy) · Derivative | 17,500 | $0.00 Strike: $60.96 | $0.00 |
DisclosureSEC source: 0001209191-21-040094 · doc4.xml · derivative · entry 2 REINHARDT MAX · CIK 0001780058 · President, Rest of World 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Underlying: Common Stock · 17,500 shares Expires 2031-06-09 F2 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| June 09, 2021 Filed Jun 12, 2021 00:40 UTC |
REINHARDT MAXPresident, Rest of World
|
GrantCommon Stock | 7,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-040094 · doc4.xml · nonDerivative · entry 1 REINHARDT MAX · CIK 0001780058 · President, Rest of World 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2022, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 09, 2021 Filed Jun 12, 2021 00:39 UTC |
RIKER LAURENVice President, Finance
|
GrantStock Option (Right to Buy) · Derivative | 6,500 | $0.00 Strike: $60.96 | $0.00 |
DisclosureSEC source: 0001209191-21-040092 · doc4.xml · derivative · entry 3 Riker Lauren Bullaro · CIK 0001545439 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,500 Underlying: Common Stock · 6,500 shares Expires 2031-06-09 F3 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| June 09, 2021 Filed Jun 12, 2021 00:39 UTC |
RIKER LAURENVice President, Finance
|
GrantCommon Stock | 2,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-040092 · doc4.xml · nonDerivative · entry 1 Riker Lauren Bullaro · CIK 0001545439 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,734 F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2022, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 09, 2021 Filed Jun 12, 2021 00:37 UTC |
WINSTON ROYChief Clinical Officer
|
GrantStock Option (Right to Buy) · Derivative | 17,500 | $0.00 Strike: $60.96 | $0.00 |
DisclosureSEC source: 0001209191-21-040089 · doc4.xml · derivative · entry 2 WINSTON ROY · CIK 0001751757 · Chief Clinical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Underlying: Common Stock · 17,500 shares Expires 2031-06-09 F2 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| June 09, 2021 Filed Jun 12, 2021 00:37 UTC |
WINSTON ROYChief Clinical Officer
|
GrantCommon Stock | 7,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-040089 · doc4.xml · nonDerivative · entry 1 WINSTON ROY · CIK 0001751757 · Chief Clinical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,035 F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2022, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 09, 2021 Filed Jun 12, 2021 00:34 UTC |
LARANJEIRA CHARLES ANTHONYChief Technical Officer
|
GrantStock Option (Right to Buy) · Derivative | 17,500 | $0.00 Strike: $60.96 | $0.00 |
DisclosureSEC source: 0001209191-21-040086 · doc4.xml · derivative · entry 2 LARANJEIRA CHARLES ANTHONY · CIK 0001524338 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Underlying: Common Stock · 17,500 shares Expires 2031-06-09 F2 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| June 09, 2021 Filed Jun 12, 2021 00:34 UTC |
LARANJEIRA CHARLES ANTHONYChief Technical Officer
|
GrantCommon Stock | 7,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-040086 · doc4.xml · nonDerivative · entry 1 LARANJEIRA CHARLES ANTHONY · CIK 0001524338 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,681 F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2022, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 09, 2021 Filed Jun 12, 2021 00:33 UTC |
Kronenfeld Mark A.Director
|
GrantStock Option (Right to Buy) · Derivative | 7,626 | $0.00 Strike: $60.96 | $0.00 |
DisclosureSEC source: 0001209191-21-040085 · doc4.xml · derivative · entry 2 Kronenfeld Mark A. · CIK 0001578074 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,626 Underlying: Common Stock · 7,626 shares Expires 2031-06-09 Read SEC document |
| June 09, 2021 Filed Jun 12, 2021 00:33 UTC |
Kronenfeld Mark A.Director
|
GrantCommon Stock | 1,066 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-040085 · doc4.xml · nonDerivative · entry 1 Kronenfeld Mark A. · CIK 0001578074 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,737 F1 · shares: Represents restricted stock units that vest on June 3, 2022, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 09, 2021 Filed Jun 12, 2021 00:31 UTC |
CHRISTIE CHRISTOPHERDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,626 | $0.00 Strike: $60.96 | $0.00 |
DisclosureSEC source: 0001209191-21-040080 · doc4.xml · derivative · entry 2 CHRISTIE CHRISTOPHER · CIK 0001787688 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,626 Underlying: Common Stock · 7,626 shares Expires 2031-06-09 Read SEC document |
| June 09, 2021 Filed Jun 12, 2021 00:31 UTC |
CHRISTIE CHRISTOPHERDirector
|
GrantCommon Stock | 1,066 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-040080 · doc4.xml · nonDerivative · entry 1 CHRISTIE CHRISTOPHER · CIK 0001787688 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,326 F1 · shares: Represents restricted stock units that vest on June 3, 2022, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 08, 2021 Filed Jun 10, 2021 18:07 UTC |
Manning Donald C.Chief Medical Officer
|
SaleCommon Stock | 2,600 | $61.14 | $158,964.00 |
DisclosureSEC source: 0001209191-21-039610 · doc4.xml · nonDerivative · entry 1 Manning Donald C. · CIK 0001775268 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,520 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.130 to $61.175, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth this footnote. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 20:16 UTC |
REINHARDT MAXPresident, Rest of World
|
SaleCommon Stock | 2,278 | $60.50 | $137,819.00 |
DisclosureSEC source: 0001209191-21-038889 · doc4.xml · nonDerivative · entry 2 REINHARDT MAX · CIK 0001780058 · President, Rest of World 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,500 F2 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| June 04, 2021 Filed Jun 8, 2021 16:17 UTC |
Reinhart Charles A. IIIChief Financial Officer
|
SaleCommon Stock | 2,648 | $61.04 | $161,625.98 |
DisclosureSEC source: 0001209191-21-038891 · doc4.xml · nonDerivative · entry 1 Reinhart Charles A. III · CIK 0001470871 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,799 F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. Read SEC document |
| June 04, 2021 Filed Jun 8, 2021 20:20 UTC |
WILLIAMS KRISTENChief Administrative Officer
|
SaleCommon Stock | 3,930 | $61.04 | $239,875.41 |
DisclosureSEC source: 0001209191-21-038901 · doc4.xml · nonDerivative · entry 1 Williams Kristen Marie · CIK 0001296965 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,957 F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. Read SEC document |
| June 04, 2021 Filed Jun 8, 2021 16:18 UTC |
STACK DAVID MDirector · CEO and Chairman
|
SaleCommon Stock | 14,905 | $61.04 | $909,756.49 |
DisclosureSEC source: 0001209191-21-038897 · doc4.xml · nonDerivative · entry 1 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,156 F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. Read SEC document |
| June 04, 2021 Filed Jun 8, 2021 20:13 UTC |
HASTINGS PAUL JDirector
|
SaleCommon Stock | 630 | $62.19 | $39,179.70 |
DisclosureSEC source: 0001209191-21-038878 · doc4.xml · nonDerivative · entry 1 HASTINGS PAUL J · CIK 0001309702 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,486 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F2 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. Read SEC document |
| June 04, 2021 Filed Jun 8, 2021 20:20 UTC |
WINSTON ROYChief Clinical Officer
|
SaleCommon Stock | 2,276 | $61.04 | $138,920.21 |
DisclosureSEC source: 0001209191-21-038903 · doc4.xml · nonDerivative · entry 1 WINSTON ROY · CIK 0001751757 · Chief Clinical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,035 F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. Read SEC document |
| June 04, 2021 Filed Jun 8, 2021 20:17 UTC |
RIKER LAURENVice President, Finance
|
SaleCommon Stock | 1,047 | $61.04 | $63,905.74 |
DisclosureSEC source: 0001209191-21-038894 · doc4.xml · nonDerivative · entry 1 Riker Lauren Bullaro · CIK 0001545439 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,134 F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. Read SEC document |
| June 04, 2021 Filed Jun 8, 2021 20:16 UTC |
REINHARDT MAXPresident, Rest of World
|
SaleCommon Stock | 1,222 | $61.04 | $74,587.21 |
DisclosureSEC source: 0001209191-21-038889 · doc4.xml · nonDerivative · entry 1 REINHARDT MAX · CIK 0001780058 · President, Rest of World 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,778 F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. Read SEC document |
| June 04, 2021 Filed Jun 8, 2021 20:15 UTC |
McLoughlin DennisChief Customer Officer
|
SaleCommon Stock | 1,895 | $61.04 | $115,665.12 |
DisclosureSEC source: 0001209191-21-038884 · doc4.xml · nonDerivative · entry 1 McLoughlin Dennis · CIK 0001752004 · Chief Customer Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,541 F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. F2 · balance_after: Includes 355 and 183 shares of common stock acquired under the issuer's employee stock purchase plan in June 2020 and December 2020, respectively. Read SEC document |
| June 04, 2021 Filed Jun 8, 2021 20:14 UTC |
LARANJEIRA CHARLES ANTHONYChief Technical Officer
|
SaleCommon Stock | 2,117 | $61.04 | $129,215.33 |
DisclosureSEC source: 0001209191-21-038881 · doc4.xml · nonDerivative · entry 1 LARANJEIRA CHARLES ANTHONY · CIK 0001524338 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,681 F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. F2 · balance_after: Includes 2 shares of common stock acquired under the issuer's employee stock purchase plan in December 2020. Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 17:27 UTC |
Manning Donald C.Chief Medical Officer
|
SaleCommon Stock | 2,380 | $62.12 | $147,852.74 |
DisclosureSEC source: 0001209191-21-038328 · doc4.xml · nonDerivative · entry 1 Manning Donald C. · CIK 0001775268 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,120 F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. Read SEC document |
| May 13, 2021 Filed Jun 12, 2021 00:47 UTC |
PACE GARY WDirector
|
GiftCommon Stock | 1,485 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-040097 · doc4.xml · nonDerivative · entry 1 PACE GARY W · CIK 0001184778 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,464 Read SEC document |
| May 12, 2021 Filed May 13, 2021 18:01 UTC |
STACK DAVID MDirector · CEO and Chairman
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 21,250 | $0.00 Strike: $10.81 | $0.00 |
DisclosureSEC source: 0001209191-21-032424 · doc4.xml · derivative · entry 12 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,670 Underlying: Common Stock · 21,250 shares Expires 2022-06-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months. Read SEC document |
| May 12, 2021 Filed May 13, 2021 18:01 UTC |
STACK DAVID MDirector · CEO and Chairman
|
SaleCommon Stock | 3,611 | $62.41 | $225,362.51 |
DisclosureSEC source: 0001209191-21-032424 · doc4.xml · nonDerivative · entry 8 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,061 F2 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.355 to $62.595, inclusive. Read SEC document |
| May 12, 2021 Filed May 13, 2021 18:01 UTC |
STACK DAVID MDirector · CEO and Chairman
|
SaleCommon Stock | 14,669 | $62.08 | $910,651.52 |
DisclosureSEC source: 0001209191-21-032424 · doc4.xml · nonDerivative · entry 7 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,672 F2 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.355 to $62.35, inclusive. Read SEC document |
| May 12, 2021 Filed May 13, 2021 18:01 UTC |
STACK DAVID MDirector · CEO and Chairman
|
SaleCommon Stock | 2,970 | $60.76 | $180,457.20 |
DisclosureSEC source: 0001209191-21-032424 · doc4.xml · nonDerivative · entry 6 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,341 F2 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.33 to $61.31, inclusive. Read SEC document |
| May 12, 2021 Filed May 13, 2021 18:01 UTC |
STACK DAVID MDirector · CEO and Chairman
|
Exercise / conversionCommon Stock | 21,250 | $10.81 | $229,712.50 |
DisclosureSEC source: 0001209191-21-032424 · doc4.xml · nonDerivative · entry 5 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,311 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| May 11, 2021 Filed May 13, 2021 18:01 UTC |
STACK DAVID MDirector · CEO and Chairman
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 21,250 | $0.00 Strike: $10.81 | $0.00 |
DisclosureSEC source: 0001209191-21-032424 · doc4.xml · derivative · entry 11 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,920 Underlying: Common Stock · 21,250 shares Expires 2022-06-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months. Read SEC document |
| May 11, 2021 Filed May 13, 2021 18:01 UTC |
STACK DAVID MDirector · CEO and Chairman
|
SaleCommon Stock | 7,932 | $61.19 | $485,359.08 |
DisclosureSEC source: 0001209191-21-032424 · doc4.xml · nonDerivative · entry 4 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,061 F2 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.00 to $61.68, inclusive. Read SEC document |
| May 11, 2021 Filed May 13, 2021 18:01 UTC |
STACK DAVID MDirector · CEO and Chairman
|
SaleCommon Stock | 13,318 | $60.78 | $809,468.04 |
DisclosureSEC source: 0001209191-21-032424 · doc4.xml · nonDerivative · entry 3 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,993 F2 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.00 to $60.995, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 3 through 7. Read SEC document |
| May 11, 2021 Filed May 13, 2021 18:01 UTC |
STACK DAVID MDirector · CEO and Chairman
|
Exercise / conversionCommon Stock | 21,250 | $10.81 | $229,712.50 |
DisclosureSEC source: 0001209191-21-032424 · doc4.xml · nonDerivative · entry 2 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,311 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| April 13, 2021 Filed Apr 16, 2021 00:35 UTC |
WILLIAMS KRISTENChief Administrative Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,339 | $0.00 Strike: $43.54 | $0.00 |
DisclosureSEC source: 0001209191-21-026889 · doc4.xml · derivative · entry 10 Williams Kristen Marie · CIK 0001296965 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,010 Underlying: Common Stock · 6,339 shares Expires 2029-06-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| April 13, 2021 Filed Apr 16, 2021 00:35 UTC |
WILLIAMS KRISTENChief Administrative Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 8,859 | $0.00 Strike: $38.35 | $0.00 |
DisclosureSEC source: 0001209191-21-026889 · doc4.xml · derivative · entry 9 Williams Kristen Marie · CIK 0001296965 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,765 Underlying: Common Stock · 8,859 shares Expires 2028-06-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| April 13, 2021 Filed Apr 16, 2021 00:35 UTC |
WILLIAMS KRISTENChief Administrative Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,125 | $0.00 Strike: $44.20 | $0.00 |
DisclosureSEC source: 0001209191-21-026889 · doc4.xml · derivative · entry 8 Williams Kristen Marie · CIK 0001296965 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,375 Underlying: Common Stock · 4,125 shares Expires 2027-06-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vested as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remained in continuous service with the issuer as of each vesting date. Read SEC document |
| April 13, 2021 Filed Apr 16, 2021 00:35 UTC |
WILLIAMS KRISTENChief Administrative Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $32.35 | $0.00 |
DisclosureSEC source: 0001209191-21-026889 · doc4.xml · derivative · entry 7 Williams Kristen Marie · CIK 0001296965 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,500 shares Expires 2026-12-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vested as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remained in continuous service with the issuer as of each vesting date. Read SEC document |
| April 13, 2021 Filed Apr 16, 2021 00:35 UTC |
WILLIAMS KRISTENChief Administrative Officer
|
SaleCommon Stock | 7,030 | $68.11 | $478,813.30 |
DisclosureSEC source: 0001209191-21-026889 · doc4.xml · nonDerivative · entry 6 Williams Kristen Marie · CIK 0001296965 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,887 F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.96 to $68.41, inclusive. Read SEC document |
| April 13, 2021 Filed Apr 16, 2021 00:35 UTC |
WILLIAMS KRISTENChief Administrative Officer
|
SaleCommon Stock | 14,793 | $66.40 | $982,255.20 |
DisclosureSEC source: 0001209191-21-026889 · doc4.xml · nonDerivative · entry 5 Williams Kristen Marie · CIK 0001296965 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,917 F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.96 to $67.95, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 3. Read SEC document |
| April 13, 2021 Filed Apr 16, 2021 00:35 UTC |
WILLIAMS KRISTENChief Administrative Officer
|
Exercise / conversionCommon Stock | 6,339 | $43.54 | $276,000.06 |
DisclosureSEC source: 0001209191-21-026889 · doc4.xml · nonDerivative · entry 4 Williams Kristen Marie · CIK 0001296965 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,710 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| April 13, 2021 Filed Apr 16, 2021 00:35 UTC |
WILLIAMS KRISTENChief Administrative Officer
|
Exercise / conversionCommon Stock | 8,859 | $38.35 | $339,742.65 |
DisclosureSEC source: 0001209191-21-026889 · doc4.xml · nonDerivative · entry 3 Williams Kristen Marie · CIK 0001296965 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,371 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| April 13, 2021 Filed Apr 16, 2021 00:35 UTC |
WILLIAMS KRISTENChief Administrative Officer
|
Exercise / conversionCommon Stock | 4,125 | $44.20 | $182,325.00 |
DisclosureSEC source: 0001209191-21-026889 · doc4.xml · nonDerivative · entry 2 Williams Kristen Marie · CIK 0001296965 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,512 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| April 13, 2021 Filed Apr 16, 2021 00:35 UTC |
WILLIAMS KRISTENChief Administrative Officer
|
Exercise / conversionCommon Stock | 2,500 | $32.35 | $80,875.00 |
DisclosureSEC source: 0001209191-21-026889 · doc4.xml · nonDerivative · entry 1 Williams Kristen Marie · CIK 0001296965 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,387 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.